Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
Shikonin (SHK) is a pleiotropic agent with remarkable cell growth inhibition activity against various cancer types, especially non–small cell lung cancer (NSCLC), but its molecular mechanism is still unclear. Our previous study found that miR-628-3p could inhibit the growth of A549 cells and induce...
Guardado en:
Autores principales: | Jieli Pan, Meiya Li, Fenglin Yu, Feiye Zhu, Linyan Wang, Dandan Ning, Xiaoli Hou, Fusheng Jiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/37f8f2e0ccb14e8dafed70c71211a9dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Shikonin Induced Program Cell Death through Generation of Reactive Oxygen Species in Renal Cancer Cells
por: Ming-Feng Tsai, et al.
Publicado: (2021) -
Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway
por: Yuzhen Zhu, et al.
Publicado: (2019) -
Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle
por: Su Y, et al.
Publicado: (2017) -
The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
por: Danrui Cui, et al.
Publicado: (2021) -
Role of microRNAs in COVID-19 with implications for therapeutics
por: Nahid Arghiani, et al.
Publicado: (2021)